Folate Intake, MTHFR Polymorphisms, and the Risk of Colorectal Cancer: A Systematic Review and Meta-Analysis
Journal of Cancer Epidemiology · 2012 · 2012 · 1-24
DOI: 10.1155/2012/952508 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Cancer Epidemiology, 2012. Verfasst von Deborah A Kennedy und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, Canada M…. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Background
The objective was to determine whether relationships exist between the methylene-tetrahydrofolate reductase ( MTHFR ) polymorphisms and risk of colorectal cancer (CRC) and examine whether the risk is modified by level of folate intake.
Methods
MEDLINE, Embase, and SCOPUS were searched to May 2012 using the terms “folic acid,” “folate,” “colorectal cancer,” “methylenetetrahydrofolate reductase,” “ MTHFR .” Observational studies were included which (1) assessed the risk of CRC for each polymorphism and/or (2) had defined levels of folate intake for each polymorphism and assessed the risk of CRC.
Results
From 910 references, 67 studies met our criteria; hand searching yielded 10 studies. The summary risk estimate comparing the 677 CT versus CC genotype was 1.02 (95% CI 0.95–1.10) and for 677 TT versus CC was 0.88 (95% CI 0.80–0.96) both with heterogeneity. The summary risk estimates for A1298C polymorphisms suggested no reduced risk. The summary risk estimate for high versus low total folate for the 677 CC genotype was 0.70 (95% CI 0.56–0.89) and the 677 TT genotype 0.63 (95% CI 0.41–0.97).
Conclusion
These results suggest that the 677 TT genotype is associated with a reduced risk of developing CRC, under conditions of high total folate intake, and this associated risk remains reduced for both MTHFR 677 CC and TT genotypes.
Autor:innen und Institutionen
- The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, Canada M5G 1X8 ; Leslie Dan Faculty of Pharmacy, University of Toronto, 144 Co…
Zitieren
APA
Kennedy, D. A., Stern, S. J., Matok, I., Moretti, M. E., Sarkar, M., Adams-Webber, T., & Koren, G. (2012). Folate Intake, MTHFR Polymorphisms, and the Risk of Colorectal Cancer: A Systematic Review and Meta-Analysis. Journal of Cancer Epidemiology, 2012, 1-24. https://doi.org/10.1155/2012/952508
Vancouver
Kennedy DA, Stern SJ, Matok I, Moretti ME, Sarkar M, Adams-Webber T, et al. Folate Intake, MTHFR Polymorphisms, and the Risk of Colorectal Cancer: A Systematic Review and Meta-Analysis. Journal of Cancer Epidemiology. 2012;2012:1-24. doi:10.1155/2012/952508
BibTeX
@article{Kennedy2012,
author = {Kennedy, Deborah A and Stern, Seth J and Matok, Ilan and Moretti, Myla E and Sarkar, Moumita and Adams-Webber, Thomasin and Koren, Gideon},
title = {Folate Intake, MTHFR Polymorphisms, and the Risk of Colorectal Cancer: A Systematic Review and Meta-Analysis},
journal = {Journal of Cancer Epidemiology},
year = {2012},
volume = {2012},
pages = {1--24},
doi = {10.1155/2012/952508}
}
EUVIMED